DocumentUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
| | |
|
| SCHEDULE 14A |
| (Rule 14a-101) |
| INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION |
| Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 |
|
| | | | | |
| Filed by the Registrant ☒ |
| Filed by a Party other than the Registrant ☐ |
|
| Check the appropriate box: |
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
| | |
|
| Recursion Pharmaceuticals, Inc. |
| (Exact name of registrant as specified in its charter) |
|
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
|
| | | | | |
| Payment of Filing Fee (Check the appropriate box): |
| ☒ | No fee required. |
| |
| |
| ☐ | Fee paid previously with preliminary materials. |
| |
| |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
| |
